Bleeding Control Kit Market Overview
Global Bleeding Control Kit Market reached US$ 4.5 billion in 2025 and is expected to reach US$ 5.9 billion by 2035, growing at a CAGR of 2.9% during the forecast period 2026-2035.
Bleeding control kits, also known as trauma kits or Stop the Bleed kits, are designed to provide essential supplies to professional first responders or bystanders to stop life-threatening bleeding.
Bleeding Control Kit Market Scope
| Metrics | Details |
| CAGR | 2.9% |
| Market Size Available for Years | 2025-2035 |
| Estimation Forecast Period | 2026-2035 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product Type, Application, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report – Request for Sample
Bleeding Control Kit Market Dynamics: Drivers & Restraints
Increasing Number of Surgeries
The global surgical tourniquets market is growing rapidly due to the increasing number of orthopedic and plastic surgeries. For instance, in 2020, hip replacements were conducted 294 times per 100,000 residents in Germany and between 250 and 269 times per 100 000 inhabitants in Finland, Austria, the Netherlands, and Denmark. Knee replacements varied more between the EU Member States than did hip replacements. Moreover, according to the American Joint Replacement Registry 2021, over 2.4 million hip and knee surgeries from over 1150 institutions took place in 2021, representing an 18.3% increase in total procedural volume compared with that in 2020.
Lack of Training and Awareness
However, the lack of training and awareness is expected to hinder the global market growth during the forecast period. Additionally, injuries caused by the bleeding kit component, such as tourniquet injuries, are also expected to hinder the global market growth during the forecast period.
Bleeding Control Kit Market Segmentation
The global bleeding control kit market is segmented based on product type, application, end user and region.
Tourniquets Product Type Segment is Expected to Dominate Market
Tourniquets, which are devices used to stop or slow bleeding by compressing blood vessels, are expected to dominate the global market during the forecast period due to government initiatives and their safety. For example, in May 2019, the U.S. Department of Defense's Committee on Tactical Combat Casualty Care (CoTCCC) recommended SAM Medical's SAM XT Extremity Tourniquet (SAM XT). Moreover, a study conducted in Los Angeles County, California, in August 2021 found that increased tourniquet use over the last few years has improved outcomes for trauma patients without increasing amputation risks.
Bleeding Control Kit Market Geographical Share
North America is Expected to Dominate the Global Market
North America is expected to dominate the global market during the forecast period due to the increasing number of surgeries conducted and trauma accidents in the region. For instance, in 2020, around 15.6 million cosmetic procedures were performed, including 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures, and about 6.8 million reconstructive procedures were performed, according to the American Society of Plastic Surgeons. Moreover, data obtained from the U.S. Department of Transportation's fatality analysis reporting system revealed that around 35,766 fatal vehicle crashes occurred in the U.S. in 2020, causing around 38,824 deaths.
Bleeding Control Kit Market Key Developments
- July 2026 – Updated EMS protocols continued to include bleeding-control procedures: The Ada County–City Emergency Services System’s 2026 EMS protocols include basic bleeding control procedures such as wound packing, hemostatic agents and tourniquet use. This reflects continued incorporation of hemorrhage-control equipment into emergency-response practice.
- 2026 – Continued regulatory recognition of advanced hemorrhage-control devices: U.S. FDA regulations continue to classify specialized devices such as nonabsorbable expandable hemostatic sponges and hemostatic gauze for temporary bleeding control. The regulatory framework specifies performance, sterility, shelf-life and human-factors requirements for emergency use.
- 2026 – Emergency bleeding-control training remains part of public preparedness: Stop the Bleed programs continue to promote training that enables bystanders to respond to life-threatening bleeding before professional medical help arrives. The program also supports access to dedicated bleeding-control kits.
Bleeding Control Kit Market Major Players
The major global players in the market include VBM Medizintechnik GmbH, TyTek Medical, TacMed Solutions, SAM MEDICAL, Delfi Medical Innovations Inc., North American Rescue, LLC., Adventure Ready Brands, ZOLL Medical Corporation, FareTec Inc. and H&H Medical
Why Purchase the Report?
- To visualize the global bleeding control kit market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of bleeding control kit market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key product of all the major players.
The global bleeding control kit market report would provide approximately 61 tables, 65 figures and 186 pages.
Target Audience 2026
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
